Updated Community Data Reports [Q3 2023]: Addressing Gaps, Achieving Growth and Quality Improvement

Updated Community Data Reports [Q3 2023]: Addressing Gaps, Achieving Growth and Quality Improvement

The Great Plains QIN team strives to improve healthcare quality and patient outcomes. We work with partners and community coalitions to identify areas for improvement, which include reducing avoidable hospital admissions and readmissions, including those caused by...
Access To Treatment For Opioid-Related Conditions In North Dakota | NDSU CAP Center ONE Program

Access To Treatment For Opioid-Related Conditions In North Dakota | NDSU CAP Center ONE Program

Buprenorphine/naloxone (Suboxone) and naloxone (Narcan) are effective harm-reduction medications used in the treatment of opioid-related conditions. Due to the rurality of North Dakota, ensuring access to treatment for opioid-related conditions is vital. Standing...
We Are Safer Together | Patient Safety Awareness Week

We Are Safer Together | Patient Safety Awareness Week

March 10 – 16 is Patient Safety Awareness Week;  an annual recognition event to grow awareness about patient safety and to recognize the work being done to reduce harm. Properly engaging patients, caregivers, and providers; integrating quality improvement...
Center of Excellence for Behavioral Health in Nursing Facilities Update and Upcoming Events

Center of Excellence for Behavioral Health in Nursing Facilities Update and Upcoming Events

Bipolar disorder is a brain disorder that causes extreme mood swings, including emotional highs (hypomania and mania) and lows (depression). These mood swings can affect sleep, energy, activity, judgment, behavior, and the ability to think clearly. In honor of Bipolar...
Ensuring Nursing Homes Residents are Free of Any Significant Medication Errors

Ensuring Nursing Homes Residents are Free of Any Significant Medication Errors

Medication errors can have serious – and, even, deadly – impacts on nursing home residents. Nevertheless, they are a common problem in too many nursing homes. Too often, medication is given to residents in a manner that conflicts with manufacturer’s instructions or...
CDC COCA Call: Overdoses Involving Xylazine Mixed with Fentanyl: Clinical and Public Health Implications

CDC COCA Call: Overdoses Involving Xylazine Mixed with Fentanyl: Clinical and Public Health Implications

During this COCA Call, presenters will discuss the epidemiology of overdoses involving xylazine mixed with fentanyl, the current understanding of health risks related to these overdoses, and acute treatment strategies. The non-opioid drug xylazine has been found in...
Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series

Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series

More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder in 2020.1 However, fewer than 1 in 5 Medicare beneficiaries with an opioid use disorder (OUD) diagnosis received medication to treat this condition. In addition, the number of patients...
2024 Webinar Series – Rural to Urban Partners: Working Together on Antimicrobial Stewardship

2024 Webinar Series – Rural to Urban Partners: Working Together on Antimicrobial Stewardship

View Lynde Monson, PharmD, BCPS, as she navigates us through the latest immunization updates and details how immunizations prevent antibiotic use. The recording is available to be viewed on the CAP Center website and there is CE available! Access the Recording  ...
Buprenorphine Prescribing Update: Waiver Elimination (MAT Act)

Buprenorphine Prescribing Update: Waiver Elimination (MAT Act)

Announced by the Substance Abuse and Mental Health Services Administration, clinicians no longer need a federal waiver to prescribe buprenorphine for treatment of opioid use disorder. However, clinicians are still required to register with the federal Drug Enforcement...